MGTX Earnings Date: Nov 12, 2026 (Estimated) — MeiraGTx Holdings plc
NASDAQ · Healthcare · Biotechnology
Updated
When is MGTX's next earnings date?
MeiraGTx Holdings plc (MGTX) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.46 on revenue of $7.0M.
How did MGTX do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), MeiraGTx Holdings plc posted EPS of $1.71 versus the -$0.46 estimate, a beat of 507.1%. Revenue was $321.4M against a $700,000 estimate. The stock's 1-day post-earnings move was -2.2%.
How much does MGTX stock move after earnings?
MGTX beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.4% (up or down) in the day after earnings.
About MeiraGTx Holdings plc
MeiraGTx Holdings plc operates as a clinical-stage gene therapy company, dedicated to pioneering therapeutic solutions for individuals afflicted by serious illnesses. Its development efforts span a broad spectrum of conditions, encompassing ocular diseases like inherited forms of blindness, as well as xerostomia (dry mouth) that often follows radiation treatment for head and neck cancers. The company also targets various degenerative and neurodegenerative disorders, notably amyotrophic lateral sclerosis (ALS) and Parkinson's disease. Currently, several of its programs are in active clinical development, including Phase 1/2 trials for Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, radiation-induced Xerostomia, and Parkinson's. MeiraGTx is also preparing to commence a clinical program for xerostomia linked to Sjogren's syndrome and maintains preclinical initiatives for other neurodegenerative conditions. A key collaboration exists with Janssen Pharmaceuticals, Inc. to advance regulatable gene therapy treatments, leveraging MeiraGTx's proprietary riboswitch technology. Established in 2015, MeiraGTx Holdings plc is headquartered in New York, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.46 | 1.71 | +507.14% | $321.4M | ✅ Beat | -2.24% | +15.51% | -1.31% |
| 2026-05-14 | Q1 2026 | -0.44 | -0.57 | -29.55% | $293,000 | ❌ Miss | -0.20% | -3.91% | -3.81% |
| 2026-03-26 | Q4 2025 | -0.61 | 0.19 | +131.15% | $75.4M | ✅ Beat | -1.18% | +19.29% | +21.13% |
| 2025-11-13 | Q3 2025 | -0.49 | -0.62 | -26.53% | $410,000 | ❌ Miss | -4.62% | -12.47% | +3.00% |
| 2025-08-14 | Q2 2025 | -0.52 | -0.48 | +7.69% | $3.7M | ✅ Beat | -0.12% | -9.35% | -8.75% |
| 2025-03-13 | Q4 2024 | -0.48 | -0.50 | -4.17% | $21.4M | ❌ Miss | +28.71% | +21.22% | -20.90% |
| 2024-11-13 | Q3 2024 | -0.52 | -0.55 | -5.77% | $10.9M | ❌ Miss | +5.71% | -10.21% | -9.76% |
| 2024-08-12 | Q2 2024 | -0.40 | -0.76 | -90.00% | $282,000 | ❌ Miss | -8.47% | -3.20% | -6.87% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $116.8M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| Related Party Service Revenue | 89.8% | $104.9M | +2742.2% | $410K | $2.3M | $293K | $104.9M |
| Service | 10.2% | $11.9M | — | — | — | — | $11.9M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.